Natsuko Watanabe Selected Research

Methimazole (Thiamazole)

1/2022	Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association.
1/2020	Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
10/2015	Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
5/2014	Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
7/2012	Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
2/2007	The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Natsuko Watanabe Research Topics

Disease

19	Graves Disease (Basedow Disease) 01/2022 - 02/2007
4	Hyperthyroidism 01/2022 - 10/2015
4	Thyroid Diseases (Thyroid Disease) 01/2022 - 01/2011
4	Thyrotoxicosis 11/2021 - 07/2012
4	Agranulocytosis (Granulocytopenia) 05/2014 - 02/2007
3	Graves Ophthalmopathy 01/2018 - 07/2015
2	Disease Progression 06/2021 - 01/2020
2	Lymphoma (Lymphomas) 01/2020 - 06/2014
2	Neoplasms (Cancer) 06/2011 - 11/2009
1	COVID-19 01/2022
1	Foreign Bodies (Foreign Body) 01/2022
1	Myocardial Infarction 11/2021
1	Anaphylaxis (Anaphylactic Shock) 07/2021
1	Congenital Abnormalities (Deformity) 03/2021
1	Otitis Media 02/2021
1	Earache (Otalgia) 02/2021
1	Meningitis 02/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2021
1	Hearing Loss (Hearing Impairment) 02/2021
1	Rare Diseases (Rare Disease) 02/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2021
1	Chemical and Drug Induced Liver Injury 10/2019
1	Neutropenia 01/2018
1	Constipation 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Fetal Diseases (Embryopathy) 10/2015
1	Chronic Thyroiditis 01/2015
1	Thyroid Nodule (Nodule, Thyroid) 01/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2014
1	Thyroid Neoplasms (Thyroid Cancer) 01/2014
1	Vasculitis (Vasculitides) 01/2014
1	Pancytopenia 01/2012
1	Infections 01/2012
1	Cushing Syndrome 06/2011
1	Neoplasm Metastasis (Metastasis) 06/2011
1	Adrenal Rest Tumor 06/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2011
1	Inflammation (Inflammations) 01/2011
1	Thyroiditis 01/2011
1	Breast Neoplasms (Breast Cancer) 11/2009
1	Exanthema (Rash) 04/2009
1	Fever (Fevers) 04/2009

Drug/Important Bio-Agent (IBA)

9	Antithyroid Agents (Antithyroid Drugs)IBA 03/2021 - 01/2012
6	Methimazole (Thiamazole)FDA LinkGeneric 01/2022 - 02/2007
5	Propylthiouracil FDA Link 03/2021 - 04/2009
4	Potassium Iodide (Pima)FDA Link 06/2020 - 10/2015
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 01/2011
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 06/2021 - 01/2011
2	thyrotropin-binding inhibitory immunoglobulinIBA 06/2021 - 01/2016
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2021 - 01/2014
2	Thyroid HormonesIBA 01/2020 - 01/2015
2	Long-Acting Thyroid Stimulator (LATS)IBA 01/2019 - 01/2011
2	Troleandomycin (TAO)FDA Link 01/2018 - 01/2011
2	IodineIBA 10/2015 - 01/2014
2	SteroidsIBA 01/2012 - 06/2011
2	AntibodiesIBA 01/2011 - 01/2011
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	TroponinIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	Tryptases (Tryptase)IBA 07/2021
1	IodidesIBA 01/2020
1	ParaffinIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2015
1	Rituximab (Mabthera)FDA Link 06/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 06/2011
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 06/2011
1	Steroidogenic Factor 1IBA 06/2011
1	GlucocorticoidsIBA 01/2011
1	phenylacetic acid (phenylacetate)FDA Link 11/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2009
1	Cytostatic AgentsIBA 11/2009
1	Proteins (Proteins, Gene)FDA Link 11/2009

Therapy/Procedure

10	Therapeutics 01/2022 - 02/2007
4	Drug Therapy (Chemotherapy) 01/2018 - 04/2011
1	Catheters 07/2021
1	Treatment Delay 02/2021
1	Thyroidectomy 04/2014
1	Combined Modality Therapy 04/2011
1	Radiotherapy 04/2011